Lower Rates of Staphylococcus aureus Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis

被引：3
|
作者：
Bryce, Aliya [1 ,2 ]
Davison, Sara [1 ]
Currie, Bart J. [1 ,3 ]
Birrell, Johanna M. [4 ]
Baird, Robert W. [1 ]
Abeyaratne, Asanga [3 ,5 ,6 ,7 ]
Majoni, Sandawana William [3 ,5 ,6 ,7 ]
Brewster-O'Brien, Teana [5 ]
Tong, Steven Y. C. [8 ,9 ]
机构：
[1] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia
[2] Royal Melbourne Hosp, Dept Gen Med, 300 Grattan St, Melbourne, Vic 3052, Australia
[3] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia
[4] NT Hlth, Northern Terr Ctr Dis Control, Darwin, NT, Australia
[5] Royal Darwin Hosp, Dept Nephrol, Darwin, NT, Australia
[6] Flinders Univ S Australia, Darwin, NT, Australia
[7] Royal Darwin Hosp Campus, Northern Terr Med Program, Darwin, NT, Australia
[8] Royal Melbourne Hosp, Peter Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia
[9] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Infect Dis, Melbourne, Vic, Australia
来源：
OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 08期
关键词：
antibiotic prophylaxis; bloodstream infection; hemodialysis; Staphylococcus aureus; trimethoprim-sulfamethoxazole; RISK; BACTEREMIA;
D O I：
10.1093/ofid/ofae431
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Hemodialysis is a risk factor for Staphylococcus aureus bloodstream infection (SAB). In this single-center study, SAB rates were 56% lower during the monsoonal wet season when patients on hemodialysis receive supervised melioidosis prophylaxis with trimethoprim-sulfamethoxazole. This intervention may reduce SAB rates in high-risk patients; however, further targeted studies are required. Graphical abstract https://tidbitapp.io/institutional-portal/open-forum-infectious-diseases/tidbits/lower-rates-of-staphylococcus-aureus-bloodstream-infection-in-patients-on-hemodialysis-receiving-trimethoprim-sulfamethoxazole-melioidosis-prophylaxis/update In the Northern Territory of Australia, patients on hemodialysis receive seasonal post-dialysis Trimethoprim-Sulfamethoxazole as melioidosis prophylaxis. This single-center study explored the effect of this intervention on rates of Staphylococcus Aureus bloodstream infections in this high risk group.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Trimethoprim-Sulfamethoxazole for Staphylococcus Aureus Bacteremia Prophylaxis in Patients on Hemodialysis: A Future Tool for the "Swiss Army Knife" of Antibiotics?
    Ryder, Jonathan H.
    Minter, Daniel J.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (08):
  • [2] High-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis
    Tissot-Dupont, Herve
    Gouriet, Frederique
    Oliver, Leopold
    Jamme, Matthieu
    Casalta, Jean-Paul
    Jimeno, Marie-Therese
    Arregle, Florent
    Lavoute, Cecile
    Hubert, Sandrine
    Philip, Mary
    Martel, Helene
    Riberi, Alberto
    Habib, Gilbert
    Raoult, Didier
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (02) : 143 - 148
  • [3] TRIMETHOPRIM-SULFAMETHOXAZOLE COMPARED WITH VANCOMYCIN FOR THE TREATMENT OF STAPHYLOCOCCUS-AUREUS INFECTION
    MARKOWITZ, N
    QUINN, EL
    SARAVOLATZ, LD
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (05) : 390 - 398
  • [4] Staphylococcus aureus, trimethoprim-sulfamethoxazole, and Wegener's granulomatosis
    Kallenberg, CGM
    Stegeman, CA
    Tervaert, JWC
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 1996, 13 (03) : 253 - 255
  • [5] Effect of trimethoprim-sulfamethoxazole prophylaxis in AIDS patients on the formation of the small colony variant phenotype of Staphylococcus aureus
    von Eiff, C
    Lubritz, G
    Heese, C
    Peters, G
    Becker, K
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 48 (03) : 191 - 194
  • [6] Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients
    Majoni, Sandawana William
    Hughes, Jaquelyne T.
    Heron, Bianca
    Currie, Bart J.
    KIDNEY INTERNATIONAL REPORTS, 2018, 3 (01): : 160 - 167
  • [7] Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections
    Khamash, Dina F.
    Voskertchian, Annie
    Tamma, Pranita D.
    Akinboyo, Ibukunoluwa C.
    Carroll, Karen C.
    Milstone, Aaron M.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2019, 8 (04) : 351 - 353
  • [8] Phenotypic Detection of Hemin-Inducible Trimethoprim-Sulfamethoxazole Heteroresistance in Staphylococcus aureus
    Nurjadi, Dennis
    Chanthalangsy, Quan
    Zizmann, Elfi
    Stuermer, Vanessa
    Moll, Maximilian
    Klein, Sabrina
    Boutin, Sebastien
    Heeg, Klaus
    Zanger, Philipp
    MICROBIOLOGY SPECTRUM, 2021, 9 (02):
  • [9] Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamethoxazole prophylaxis
    Abdel-Haq, N
    Abuhammour, W
    Asmar, B
    Thomas, R
    Dabbagh, S
    Gonzalez, R
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (07) : 647 - 649
  • [10] Trimethoprim-Sulfamethoxazole for Methicillin-Resistant Staphylococcus aureus: A Forgotten Alternative?
    Pappas, G.
    Athanasoulia, A. P.
    Matthaiou, D. K.
    Falagas, M. E.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (02) : 115 - 126
12345